Europe - Euronext Paris - EPA:NANO - FR0011341205 - Common Stock
Overall NANO gets a fundamental rating of 1 out of 10. We evaluated NANO against 86 industry peers in the Biotechnology industry. Both the profitability and financial health of NANO have multiple concerns. NANO has a expensive valuation and it also scores bad on growth.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -114.32% | ||
| ROE | N/A | ||
| ROIC | N/A |
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | N/A |
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | N/A | ||
| Debt/FCF | N/A | ||
| Altman-Z | -12.97 |
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 0.63 | ||
| Quick Ratio | 0.63 |
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A |
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | N/A | ||
| EV/EBITDA | N/A |
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0% |
ChartMill assigns a fundamental rating of 1 / 10 to NANO.PA.
ChartMill assigns a valuation rating of 1 / 10 to NANOBIOTIX (NANO.PA). This can be considered as Overvalued.
NANOBIOTIX (NANO.PA) has a profitability rating of 0 / 10.
The financial health rating of NANOBIOTIX (NANO.PA) is 0 / 10.